Ciliary Neurotrophic Factor (CNTF) Safety Trial in Patients With Macular Telangiectasia (Mactel)

Clinical trial NCT01327911 · COMPLETED

Trial details

NCT number: NCT01327911
Sponsor: Neurotech Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Idiopathic Juxtafoveal Telangiectasia

Start date: 2011-05-01
Primary completion: 2016-09-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.